0000908662-19-000238.txt : 20191101 0000908662-19-000238.hdr.sgml : 20191101 20191101162819 ACCESSION NUMBER: 0000908662-19-000238 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191101 DATE AS OF CHANGE: 20191101 EFFECTIVENESS DATE: 20191101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MindImmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001792522 IRS NUMBER: 812613707 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352431 FILM NUMBER: 191187131 BUSINESS ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 BUSINESS PHONE: 401-225-4612 MAIL ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 D 1 primary_doc.xml X0708 D LIVE 0001792522 MindImmune Therapeutics, Inc. 130 FLAGG ROAD KINGSTON RI RHODE ISLAND 02881 401-225-4612 DELAWARE None None Corporation true 2016 Stevin Zorn 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Director Robert B. Nelson 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Director Frank S. Menniti 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Director Richard G. Horan 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-22 false true false 0 3000000 750000 2250000 false 8 0 0 875000 true Estimate of gross proceeds of the $3 million offering which, if fully subscribed, has been or is proposed to be used for payments to persons identified in Item 3, being compensation for services rendered as key employees or consultants to the company. false MindImmune Therapeutics, Inc. /s/ Stevin Zorn Stevin Zorn President 2019-11-01